CITES Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
25
- Investments
-
46
- Portfolio
-
22
- Exits
-
6
CITES General Information
Company Description
Founded in 2013, CITES is a deeptech venture capital based in Sunchales, Argentina. The firm seeks to invest from early stages to Series A, with hands-on support in intellectual property, regulatory affairs, strategy, and fundraising to transform scientific breakthroughs into global business.
Business Details
Website
www.cites-gss.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Avenida Belgrano 758
- Sunchales, Santa Fe 2322
- Argentina
CITES Investments (46)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NeoCrop Technologies | 04-Oct-2026 | Seed Round | Other Agriculture | Startup | ||
| Odycell Nanotherapies | 12-Aug-2026 | Biotechnology | Generating Revenue | |||
| Ab Astra | 08-Jun-2026 | Other Metals, Minerals and Mining | Startup | |||
| Amnova Biotech | 01-Mar-2026 | Drug Discovery | Generating Revenue | |||
| Baxxis Medtech | 01-Jan-2026 | Therapeutic Devices | Startup | |||
| Clover (Diagnostic Equipment) | 06-Oct-2025 | Diagnostic Equipment | Generating Revenue | |||
| Single Strand Biotech | 19-Sep-2025 | Biotechnology | Startup | |||
| Ab Astra | 01-Aug-2025 | Other Metals, Minerals and Mining | Startup | |||
| Bioseek (Agricultural Chemicals) | 19-May-2025 | Early Stage VC | Agricultural Chemicals | Startup | ||
| Crinsurance | 31-Mar-2025 | Later Stage VC | Other Devices and Supplies | Generating Revenue |
CITES Exits (6)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| EpiLiquid | 22-Jan-2026 | Out of Business | |
| Selectivity Life | 07-Jul-2025 | ||
| Gbot | 01-Jun-2025 | ||
| Bionirs | |||
| Nectras | Out of Business | ||
| NeuroAcoustics | Secondary Transaction - Private |
CITES Investments by Industry, Year, and Region
CITES Co-Investors (25)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| AIR Capital | 2 |
|
|
||
| Zentynel Frontier Investments |
|
|
|||
| Ag-West Bio |
|
|
|||
| Inder |
|
|
|||
| StartUp Health |
|
|
CITES FAQs
-
What is CITES?
Founded in 2013, CITES is a deeptech venture capital based in Sunchales, Argentina.
-
When was CITES founded?
CITES was founded in 2013.
-
Where is CITES headquartered?
CITES is headquartered in Sunchales, Argentina.
-
What is CITES's total asset value?
CITES has around in total assets under management.
-
How many investments has CITES made?
CITES has made 46 investments.
-
What has CITES invested in?
CITES has made numerous investments in companies like NeoCrop Technologies, Odycell Nanotherapies, and Ab Astra within the Agriculture, Biotechnology, and Metals, Minerals and Mining industries.
-
What has CITES invested in recently?
CITES's latest investment was on 04-Oct-2026 in NeoCrop Technologies, a company within the Agriculture industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process